on ORPHAN SYNERGY EUROPE-PHARMA (EPA:OSE)
OSE Immunotherapeutics unveils its financial calendar for 2026
OSE Immunotherapeutics, located in Nantes, has announced its financial calendar for 2026. The company will publish its 2025 annual financial results on April 29, 2026, followed by its first-quarter cash position on April 30, 2026. The Annual General Meeting of Shareholders is scheduled for June 24, 2026. First-half 2026 financial results will be announced on September 28, and the third-quarter cash position will be published on October 27. Finally, the fourth-quarter cash position will be released on January 26, 2027.
This schedule is indicative and subject to change. For up-to-date information, please consult the company's official website.
R. P.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all ORPHAN SYNERGY EUROPE-PHARMA news